Ameriprise’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$119M Sell
2,161,172
-2,046,391
-49% -$112M 0.03% 495
2025
Q1
$297M Sell
4,207,563
-292,685
-7% -$20.7M 0.08% 250
2024
Q4
$296M Buy
4,500,248
+218,766
+5% +$14.4M 0.08% 256
2024
Q3
$301M Sell
4,281,482
-419,844
-9% -$29.5M 0.08% 267
2024
Q2
$387M Sell
4,701,326
-702,219
-13% -$57.8M 0.1% 204
2024
Q1
$472M Sell
5,403,545
-15,821
-0.3% -$1.38M 0.13% 171
2023
Q4
$523M Buy
5,419,366
+255,417
+5% +$24.6M 0.16% 145
2023
Q3
$457M Buy
5,163,949
+275,436
+6% +$24.4M 0.15% 149
2023
Q2
$424M Sell
4,888,513
-49,833
-1% -$4.32M 0.13% 168
2023
Q1
$480M Buy
4,938,346
+289,718
+6% +$28.2M 0.16% 147
2022
Q4
$481M Sell
4,648,628
-1,046,606
-18% -$108M 0.16% 136
2022
Q3
$483M Sell
5,695,234
-120,343
-2% -$10.2M 0.18% 124
2022
Q2
$482M Buy
5,815,577
+475,127
+9% +$39.4M 0.17% 127
2022
Q1
$412M Sell
5,340,450
-1,211,211
-18% -$93.4M 0.12% 178
2021
Q4
$579M Sell
6,551,661
-277,515
-4% -$24.5M 0.16% 131
2021
Q3
$528M Buy
6,829,176
+278,927
+4% +$21.6M 0.17% 123
2021
Q2
$547M Buy
6,550,249
+316,914
+5% +$26.4M 0.17% 133
2021
Q1
$471M Buy
6,233,335
+1,873,040
+43% +$141M 0.16% 137
2020
Q4
$382M Buy
4,360,295
+1,354,135
+45% +$119M 0.14% 159
2020
Q3
$229M Sell
3,006,160
-127,540
-4% -$9.7M 0.09% 230
2020
Q2
$387M Buy
3,133,700
+135,564
+5% +$16.7M 0.17% 132
2020
Q1
$253M Sell
2,998,136
-198,723
-6% -$16.8M 0.13% 166
2019
Q4
$270M Buy
3,196,859
+305,237
+11% +$25.8M 0.11% 192
2019
Q3
$195M Buy
2,891,622
+3,229
+0.1% +$218K 0.09% 238
2019
Q2
$247M Buy
2,888,393
+235,219
+9% +$20.1M 0.11% 196
2019
Q1
$236M Sell
2,653,174
-8,046
-0.3% -$714K 0.11% 204
2018
Q4
$227M Sell
2,661,220
-66,384
-2% -$5.65M 0.11% 195
2018
Q3
$266M Buy
2,727,604
+293,137
+12% +$28.6M 0.09% 236
2018
Q2
$229M Buy
2,434,467
+1,597,750
+191% +$150M 0.1% 205
2018
Q1
$67.8M Sell
836,717
-215,427
-20% -$17.5M 0.03% 515
2017
Q4
$93.8M Buy
1,052,144
+81,380
+8% +$7.26M 0.04% 392
2017
Q3
$90.3M Buy
970,764
+36,227
+4% +$3.37M 0.04% 393
2017
Q2
$84.9M Sell
934,537
-671,904
-42% -$61M 0.04% 400
2017
Q1
$141M Buy
1,606,441
+31,983
+2% +$2.81M 0.07% 274
2016
Q4
$130M Buy
1,574,458
+62,754
+4% +$5.2M 0.07% 282
2016
Q3
$140M Buy
1,511,704
+31,959
+2% +$2.96M 0.08% 252
2016
Q2
$115M Buy
1,479,745
+168,586
+13% +$13.1M 0.07% 278
2016
Q1
$108M Buy
1,311,159
+333,888
+34% +$27.5M 0.06% 291
2015
Q4
$102M Buy
977,271
+328,161
+51% +$34.4M 0.06% 300
2015
Q3
$68.4M Sell
649,110
-209,076
-24% -$22M 0.04% 375
2015
Q2
$117M Sell
858,186
-23,750
-3% -$3.25M 0.07% 282
2015
Q1
$110M Buy
881,936
+153,657
+21% +$19.2M 0.06% 297
2014
Q4
$65.8M Buy
728,279
+392,060
+117% +$35.4M 0.04% 432
2014
Q3
$24.3M Sell
336,219
-229,338
-41% -$16.5M 0.01% 841
2014
Q2
$35.2M Sell
565,557
-609,261
-52% -$37.9M 0.02% 701
2014
Q1
$80.1M Buy
1,174,818
+261,492
+29% +$17.8M 0.05% 361
2013
Q4
$64.2M Buy
913,326
+149,726
+20% +$10.5M 0.04% 443
2013
Q3
$55.1M Sell
763,600
-41,359
-5% -$2.99M 0.04% 494
2013
Q2
$44.9M Buy
+804,959
New +$44.9M 0.03% 555